Combination Chemotherapy Following Surgery in Treating Patients With Urinary Tract Cancer

NCT00028860 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Bladder Cancer
Transitional Cell Cancer of the Renal Pelvis and Ureter

Interventions

BIOLOGICAL: filgrastim
DRUG: carboplatin
DRUG: gemcitabine hydrochloride
DRUG: ifosfamide
DRUG: paclitaxel
PROCEDURE: adjuvant therapy

Sponsor

Tulane University Health Sciences Center